Cells, 2023 · DOI: 10.3390/cells12182317 · Published: September 20, 2023
This study investigates how regulatory T cells (Tregs) affect neuropathic pain in male and female mice after nerve injury. Tregs are a type of immune cell that can reduce inflammation and help maintain balance in the immune system. Researchers injected activated Tregs into the spinal canal of mice with nerve damage and observed how it affected their pain behavior, immune cell populations in different tissues (lymphoid, meningeal), and the activity of certain cells (microglia, astrocytes) in the spinal cord. The findings showed that Treg treatment reduced pain in both male and female mice. However, the way Tregs affected the immune system and spinal cord cells differed between the sexes, suggesting different mechanisms are at play.
Treg therapy may be a compelling therapeutic solution for treating some neuropathic pain syndromes.
Further research is required to elucidate the sex-specific mechanisms by which Tregs regulate neuropathic pain to enable their development as potential tools for pain management.
Cellular therapies utilizing Tregs have been shown to have therapeutic potential in various inflammatory and autoimmune diseases and transplant rejection.